End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.26 CNY | +5.16% | +10.14% | -24.19% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.19% | 437M | - | ||
+21.91% | 5.62B | C | ||
-11.63% | 4.38B | C- | ||
-1.01% | 3.63B | C | ||
+1.25% | 2.05B | - | - | |
-0.08% | 1.52B | B+ | ||
-13.64% | 1.24B | B | ||
-1.81% | 880M | - | D+ | |
-0.24% | 601M | - | - | |
-14.36% | 385M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603601 Stock
- Ratings Chongqing Zaisheng Technology Co., Ltd.